Rekombinanter CD40LG (Frexalimab Biosimilar) Antikörper (Biotin)
Kurzübersicht für Rekombinanter CD40LG (Frexalimab Biosimilar) Antikörper (Biotin) (ABIN7829056)
Target
Antikörpertyp
Reaktivität
Wirt
Klonalität
Konjugat
Applikation
Güteklasse
-
-
Verwendungszweck
- Biotinylated Anti-CD40 Ligand(frexalimab biosimilar) mAb
-
Isotyp
- IgG1
-
-
-
-
Applikationshinweise
- ELISA 1:5000-10000
-
Kommentare
-
Research grade biosimilar. Not for use in therapeutic or diagnostic procedures for humans or animals.
-
Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
-
-
Format
- Lyophilized
-
Rekonstitution
- Please see Certificate of Analysis for specific instructions of reconstitution.
-
Buffer
- Lyophilized from sterile PBS, pH 7.4. Normally 5 % - 8 % trehalose is added as protectants before lyophilization.
-
Lagerung
- -20 °C,-80 °C
-
Informationen zur Lagerung
- Store at -20°C to -80°C for 12 months in lyophilized form. After reconstitution, if not intended for use within a month, aliquot and store at -80°C (Avoid repeated freezing and thawing). Lyophilized proteins are shipped at ambient temperature.
-
Haltbarkeit
- 12 months
-
-
- CD40LG (Frexalimab Biosimilar)
-
Andere Bezeichnung
- Frexalimab Biosimilar
-
Substanzklasse
- Biosimilar
-
Hintergrund
-
Synonyms Target:IGM,IMD3,TRAP,gp39,CD154,CD40L,HIGM1,T-BAM,TNFSF5,hCD40L
Synonyms Antibody:INX 021,INX021,INX-021,SAR-441344,SAR441344,SAR 441344 -
UniProt
- P29965
Target
-